1. Home
  2. INDI vs NYXH Comparison

INDI vs NYXH Comparison

Compare INDI & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDI
  • NYXH
  • Stock Information
  • Founded
  • INDI 2007
  • NYXH 2009
  • Country
  • INDI United States
  • NYXH Belgium
  • Employees
  • INDI N/A
  • NYXH N/A
  • Industry
  • INDI Semiconductors
  • NYXH Medical/Dental Instruments
  • Sector
  • INDI Technology
  • NYXH Health Care
  • Exchange
  • INDI Nasdaq
  • NYXH Nasdaq
  • Market Cap
  • INDI 492.3M
  • NYXH 394.1M
  • IPO Year
  • INDI N/A
  • NYXH 2021
  • Fundamental
  • Price
  • INDI $2.39
  • NYXH $10.05
  • Analyst Decision
  • INDI Strong Buy
  • NYXH Strong Buy
  • Analyst Count
  • INDI 6
  • NYXH 4
  • Target Price
  • INDI $7.50
  • NYXH $16.25
  • AVG Volume (30 Days)
  • INDI 4.6M
  • NYXH 25.9K
  • Earning Date
  • INDI 02-20-2025
  • NYXH 03-13-2025
  • Dividend Yield
  • INDI N/A
  • NYXH N/A
  • EPS Growth
  • INDI N/A
  • NYXH N/A
  • EPS
  • INDI N/A
  • NYXH N/A
  • Revenue
  • INDI $216,682,000.00
  • NYXH $4,680,609.00
  • Revenue This Year
  • INDI $26.55
  • NYXH $22.93
  • Revenue Next Year
  • INDI $47.64
  • NYXH $411.04
  • P/E Ratio
  • INDI N/A
  • NYXH N/A
  • Revenue Growth
  • INDI N/A
  • NYXH 3.98
  • 52 Week Low
  • INDI $2.35
  • NYXH $6.76
  • 52 Week High
  • INDI $7.82
  • NYXH $20.00
  • Technical
  • Relative Strength Index (RSI)
  • INDI 27.98
  • NYXH 49.23
  • Support Level
  • INDI $2.43
  • NYXH $9.51
  • Resistance Level
  • INDI $3.12
  • NYXH $10.41
  • Average True Range (ATR)
  • INDI 0.25
  • NYXH 0.45
  • MACD
  • INDI -0.05
  • NYXH -0.05
  • Stochastic Oscillator
  • INDI 3.27
  • NYXH 36.66

About INDI indie Semiconductor Inc.

Indie Semiconductor Inc is empowering the Autotech revolution with next-generation automotive semiconductors and software platforms. It focuses on edge sensors for advanced Driver Assistance Systems including LiDAR, connected car, user experience, and electrification applications. These technologies represent the core underpinnings of both electric and autonomous vehicles, while the advanced user interfaces transform the in-cabin experience to mirror and seamlessly connect to the mobile platforms. Geographically, the company generates majority of its revenue from Greater China and rest from United States, Europe, South Korea and other regions.

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Share on Social Networks: